An Easy Solution to Lower the Time and Costs of Clinical Trials
With the technology advances we have seen in the last 10 years, it’s hard to…
With the technology advances we have seen in the last 10 years, it’s hard to…
Biosimilars will have their Polish guarantor. Polpharma, the largest Polish producer of medicines, is the…
Thanks to the synthetic biology revolution, bioluminescence is now moving from a curious natural trait…
Good news just keeps on coming from ASCO Annual Meeting. Edinburgh-based NuCana presented in two…
Abivax has ended the paperwork and launched its IPO on Euronext Paris, where the biotech…
Novartis has rejected the Israeli biotech Gamida Cell… again. The Big Pharma has decided not to carry…
MorphoSys has presented at ASCO optimistic results of MOR202’s phase I/IIa study, a candidate treatment against…
[Update] Bloomberg announced that they make wrong conclusions from their discussion with AstraZeneca's CEO Pascal…
Last week, Biotech Entrepreneurs gathered in Berlin for the Charité Entrepreneurship Summit 2015. As a spectator, I'll…
Erytech Pharma reported optimistic Phase III results of its pivotal program with GRASPA, an original…
Phase III is a critical step in a drug development process. NeuroVive Pharmaceutical has learned…
After many awards and famous collaborations, the Dutch biotech company Avantium signed a deal with…